Zolmitriptan | compare suppliers & send inquiries for free
Looking for Zolmitriptan 139264-17-8?
More information about the use of: Zolmitriptan. Zolmitriptan is a member of the triptan class of 5-hydroxytryptamine(5-HT)1B/1D/(1F) receptor agonists used to treat acute migraine Sumatriptan was the first triptan to be developed, but had poor oral bioavailability and lipophilicity. This led to the development of second-generation triptans, including almotriptan, eletriptan, frovatriptan, naratriptan, rizatriptan, and zolmitriptan. Triptans can be administered alone or in combination with an NSAID like naproxen, and represent the current gold standard for acute migraine treatment.
Zolmitriptan was first approved by the FDA for sale by Zeneca Pharmaceuticals under the trade name Zomig® on November 25, 1997. It is currently available in both tablet and nasal spray forms.
You can find more info about this product by clicking on the DB ID above.
Zolmitriptan manufacturers | traders | suppliers
We have 19 companies offering Zolmitriptan from 5 different countries.
Get in contact with the supplier of your choice:
- Inke S.A. from Spain
- Aurobindo from India
- SMS Pharma from India
- Hetero Drugs from India
- Nosch Labs from India
- Sun Pharma from India
- Emcure Pharma from India
- Mylan from India
- Dr. Reddy's from India
- Glenmark Pharma from India
- Jubilant Generics from India
- Natco Pharma from India
- Alembic Pharma from India
- Macleods Pharma from India
- Teva from Israel
- Orchid Pharma from India
- Unichem Labs. from India
- Syn-tech Chem from Taiwan
- PLIVA from Czech Republic
Let the supplier know whether you are looking for a product with a specific monograph such as EP (Ph. Eur.), USP, JP, BP or another quality. Or, whether you are looking for hydrochloride (HCl), anhydricum, base, micronisatum or a specific purity.
You can use the filters to find high-quality suppliers. For example, you can select GMP, FDA or ISO certified suppliers. Visit our FAQ page or use the chat box in the corner to get more information about Pharmaoffer.